| |
Latest 10 SEC filings (by transaction date) for BIVI within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 6/24 | Mar 4/24 | Do Cuong V | Indirect Ownership | Warrants (right to buy) | P - Open market or private purchase | 5,000 | |
Mar 6/24 | Mar 4/24 | Do Cuong V | Indirect Ownership | Common stock | P - Open market or private purchase | 10,000 | |
Dec 13/23 | Dec 11/23 | Kim Joanne Wendy | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 5,000 | |
Dec 6/23 | Dec 1/23 | Gorlin Steve | Direct Ownership | Common Stock | S - Open market or private sale | -75,680 | $1.69 |
Dec 1/23 | Nov 30/23 | Do Cuong V | Direct Ownership | Common stock | P - Open market or private purchase | 10,000 | $1.78 |
Dec 6/23 | Nov 9/23 | Lang James Paul | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 93,500 | |
Dec 6/23 | Nov 9/23 | Gorlin Steve | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 46,358 | |
Dec 6/23 | Nov 9/23 | Rogich Sigmund | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 42,254 | |
Dec 6/23 | Nov 9/23 | Hariri Robert J | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 42,254 | |
Dec 6/23 | Nov 9/23 | Sherman Michael Edward | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 89,750 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for BIVI within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 6/24 | Mar 4/24 | Do Cuong V | Indirect Ownership | Warrants (right to buy) | P - Open market or private purchase | 5,000 | |
Mar 6/24 | Mar 4/24 | Do Cuong V | Indirect Ownership | Common stock | P - Open market or private purchase | 10,000 | |
Dec 13/23 | Dec 11/23 | Kim Joanne Wendy | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 5,000 | |
Dec 6/23 | Nov 9/23 | Lang James Paul | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 93,500 | |
Dec 6/23 | Dec 1/23 | Gorlin Steve | Direct Ownership | Common Stock | S - Open market or private sale | -75,680 | $1.69 |
Dec 6/23 | Nov 9/23 | Gorlin Steve | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 46,358 | |
Dec 6/23 | Nov 9/23 | Rogich Sigmund | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 42,254 | |
Dec 6/23 | Nov 9/23 | Hariri Robert J | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 42,254 | |
Dec 6/23 | Nov 9/23 | Sherman Michael Edward | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 89,750 | |
Dec 6/23 | Nov 9/23 | Berman Richard J | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 51,830 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |
Madrigal Pharmaceuticals (OQ:MDGL) |